← All trials
NCT06238349
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 23, 2024
- Primary completion
- Jun 21, 2024
- Completion date
- Jun 28, 2024
- First posted
- Feb 2, 2024
- Last posted
- Feb 2, 2024
- Enrollment
- 200
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Zhuhai Center for Maternal and Child Health CareLead sponsor
- Zhuhai Center for Maternal and Child Health CareSponsor investigator
- Chongqing Medical UniversityCollaborator
- Chongqing Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.